For the period of 08 to 14 October 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 08 – 14 October 2022 Document Preview:
HTAC Guidance: Limited evidence of improved protection from 2nd booster dose among healthy individuals aged 18-49 years
On 22 September 2022, the HTAC submitted its findings on 2nd boosters for healthy individuals ages 18 to 49 years to the Office of the Secretary based on the best available evidence using the HTAC decision framework: Evaluation Framework The HTAD received the acceptance of the OIC-SOH of the findings on 2nd booster for healthy individual ages continue reading : HTAC Guidance: Limited evidence of improved protection from 2nd booster dose among healthy individuals aged 18-49 years
Evidence brief for 01 to 07 October 2022
For the period of 01 to 07 October 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 01 to 07 October 2022 Document Preview:
Evidence brief for 24 to 30 September 2022
For the period of 24 to 30 October 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 24– 30 September 2022 Document Preview: